COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban
Session Clinical Trial Updates
Speaker John William Eikelboom
Event : ESC Congress 2018
- Topic : preventive cardiology
- Sub-topic : Secondary Prevention
- Session type : Late-Breaking Science